← Alle mensen

AZ

Alona Zer

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-smal...

European journal of cancer (Oxford, England : 1990) · 9 september 2025

Durvalumab plus tremelimumab als eerstelijns bij gemetastaseerd NSCLC: NEPTUNE fase III

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023-01

Atezolizumab plus carboplatine-nab-paclitaxel versus chemotherapie bij NSCLC: IMpower130 fase III

The Lancet. Oncology · 2019-07